Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin's Lymphoma

被引:0
作者
Liu, Shuxian [1 ]
Xu, Minghao [1 ]
Zhong, Lei [2 ]
Tong, Xiangmin [3 ]
Qian, Suying [4 ]
机构
[1] Hangzhou Normal Univ, Sch Pharm, Key Lab Elemene Class Anticanc Chinese Med, Hangzhou 311121, Zhejiang, Peoples R China
[2] Tongxiang Hosp Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China
[3] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou 310014, Peoples R China
[4] Ningbo No 2 Hosp, Ningbo, Peoples R China
关键词
B cell lymphoma; nanobiotechnology; non-hodgkin's lymphoma; combination therapy; nano biomaterials; diagnosis; DRUG-DELIVERY SYSTEM; B-CELL LYMPHOMA; T-CELL; DOXORUBICIN CHEMOTHERAPY; FDG-PET/CT; IN-VITRO; R-CHOP; THERAPY; NANOPARTICLES; EPIDEMIOLOGY;
D O I
10.2174/1389557523666230915103121
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lymphoma is the eighth most common type of cancer worldwide. Currently, lymphoma is mainly classified into two main groups: Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL), with NHL accounting for 80% to 90% of the cases. NHL is primarily divided into B, T, and natural killer (NK) cell lymphoma. Nanotechnology is developing rapidly and has made significant contributions to the field of medicine. This review summarizes the advancements of nanobiotechnology in recent years and its applications in the treatment of NHL, especially in diffuse large B cell lymphoma (DLBCL), primary central nervous system lymphoma (PCNSL), and follicular lymphoma (FL). The technologies discussed include clinical imaging, targeted drug delivery, photodynamic therapy (PDT), and thermodynamic therapy (TDT) for lymphoma. This review aims to provide a better understanding of the use of nanotechnology in the treatment of non-Hodgkin's lymphoma.
引用
收藏
页码:895 / 907
页数:13
相关论文
共 117 条
[21]   Lymphoma Classification [J].
de Leval, Laurence ;
Jaffe, Elaine S. .
CANCER JOURNAL, 2020, 26 (03) :176-185
[22]   Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging [J].
Etrych, Tomas ;
Daumova, Lenka ;
Pokorna, Eva ;
Tuskova, Diana ;
Lidicky, Ondrej ;
Kolarova, Vera ;
Pankrac, Jan ;
Sefc, Ludek ;
Chytil, Petr ;
Klener, Pavel .
JOURNAL OF CONTROLLED RELEASE, 2018, 289 :44-55
[23]   EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity [J].
Gandhi, M. K. ;
Hoang, T. ;
Law, S. C. ;
Brosda, S. ;
O'Rourke, K. ;
Tobin, J. W. D. ;
Vari, F. ;
Murigneux, V ;
Fink, L. ;
Gunawardana, J. ;
Gould, C. ;
Oey, H. ;
Bednarska, K. ;
Delecluse, S. ;
Trappe, R. U. ;
de Long, L. Merida ;
Sabdia, M. B. ;
Bhagat, G. ;
Hapgood, G. ;
Blyth, E. ;
Clancy, L. ;
Wight, J. ;
Hawkes, E. ;
Rimsza, L. M. ;
Maguire, A. ;
Bojarczuk, K. ;
Chapuy, B. ;
Keane, C. .
BLOOD, 2021, 137 (11) :1468-1477
[24]   A Recent Review on Cancer Nanomedicine [J].
Giri, Paras Mani ;
Banerjee, Anurag ;
Layek, Buddhadev .
CANCERS, 2023, 15 (08)
[25]   Synthesizing efficacious genistein in conjugation with superparamagnetic Fe3O4 decorated with bio-compatible carboxymethylated chitosan against acute leukemia lymphoma [J].
Goorbandi, Rachel Ghasemi ;
Mohammadi, Mohammad Reza ;
Malekzadeh, Kianoosh .
BIOMATERIALS RESEARCH, 2020, 24 (01)
[26]   CAR-T cell persistence in the treatment of leukemia and lymphoma [J].
Gupta, Arjun ;
Gill, Saar .
LEUKEMIA & LYMPHOMA, 2021, 62 (11) :2587-2599
[27]   Antibody-Drug Conjugates for Cancer Therapy [J].
Hafeez, Umbreen ;
Parakh, Sagun ;
Gan, Hui K. ;
Scott, Andrew M. .
MOLECULES, 2020, 25 (20)
[28]   Biodegradable dendrimers for drug delivery [J].
Huang, Da ;
Wu, Decheng .
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2018, 90 :713-727
[29]   Photoluminescent Inorganic Nanoprobe-based Pathogen Detection [J].
Huang, Li-Li ;
Wang, Zhong-Jie ;
Xie, Hai-Yan .
CHEMISTRY-AN ASIAN JOURNAL, 2022, 17 (16)
[30]   Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view [J].
Huang, Xingyue ;
Lu, Yang ;
Guo, Mingxue ;
Du, Shouying ;
Han, Ning .
THERANOSTICS, 2021, 11 (15) :7546-7569